Revelan Eltrombopag is generally referred to as Eltrombopag ethanolamine tablets, and the side effects of this medication include anemia, insomnia, and hair loss. Eltrombopag ethanolamine tablets are clinically used to treat chronic immune thrombocytopenia. Usually such patients have poor previous response to glucocorticoids, immunoglobulins and other treatments, and by applying this drug platelets can be raised, reduced or bleeding can be prevented. Usually, the common side effects that patients experience after using the drug are anemia, insomnia, hair loss, muscle pain, and body weakness. Also, some patients experience side effects such as peripheral edema, headache, cough, itchy skin, and body weakness after using the drug. This drug is contraindicated if the patient is allergic to Eltrombopag olamine or any of the excipients. Patients should also monitor bilirubin levels during the medication period so that the dosage can be adjusted in a timely manner as prescribed by the doctor. It is recommended that patients take Etrazepam ethanolamine tablets as prescribed by the doctor, and should not use the drug indiscriminately or increase or decrease the dosage arbitrarily, in order to prevent overdose of the drug from causing mild skin rashes, transient bradycardia, etc., or the dosage is too small to achieve the effective therapeutic purpose.